BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
The fight against cancer, particularly metastatic breast cancer, has seen substantial advancements, yet it remains one of the most daunting ...
Gynecological cancers, including cervical, ovarian, and uterine cancers, persist as significant global health challenges that primarily affect women. Despite advances ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine